These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8245722)

  • 1. Identification of disulfide-linked apolipoprotein species in human lipoproteins.
    Connelly PW; Maguire GF; Vezina C; Hegele RA; Little JA
    J Lipid Res; 1993 Oct; 34(10):1717-27. PubMed ID: 8245722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein C-II deficiency revisited.
    Gotto AM
    N Engl J Med; 1984 Jun; 310(25):1664-5. PubMed ID: 6727938
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
    Huff MW; Breckenridge WC; Strong WL; Wolfe BM
    Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guinea pig apolipoprotein C-II: expression in E. coli, functional studies of recombinant wild-type and mutated variants, and distribution on plasma lipoproteins.
    Andersson Y; Lookene A; Shen Y; Nilsson S; Thelander L; Olivecrona G
    J Lipid Res; 1997 Oct; 38(10):2111-24. PubMed ID: 9374133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J; Karpe F; Milne RW; Hamsten A
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
    Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.
    Campos H; Perlov D; Khoo C; Sacks FM
    J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
    Tam SP; Dory L; Rubinstein D
    J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
    Breckenridge WC; Alaupovic P; Cox DW; Little JA
    Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In addition to the high-density lipoprotein fraction, apolipoprotein C-III is detected in chylomicrons and the very low-density lipoprotein fraction from serum of normolipidemic cows.
    Katoh N
    J Vet Med Sci; 2001 Jan; 63(1):95-7. PubMed ID: 11217073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.
    Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Vink P; Allen C; Hogg E; Brady D; Glueck CJ; Jackson RL
    J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of human plasma apolipoproteins part 1. assay of apolipoprotein-B.
    Bautovich GJ; Simons LA; Williams PF; Turtle JR
    Atherosclerosis; 1975; 21(2):217-34. PubMed ID: 165825
    [No Abstract]   [Full Text] [Related]  

  • 18. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects.
    Huff MW; Fidge NH; Nestel PJ; Billington T; Watson B
    J Lipid Res; 1981 Nov; 22(8):1235-46. PubMed ID: 7320634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
    Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.